# PanTher Therapeutics

Source: https://onco.cc/companies/panther-therapeutics/  
OnCo record `panther-therapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

PanTher Therapeutics makes absorbable patches that release chemotherapy directly at the tumour over a long period. Its first product, PTM-101, which contains paclitaxel, is in an early trial alongside standard treatment before surgery for pancreatic cancer.

## Summary

PanTher Therapeutics, Inc., with offices in Austin, Texas, and Watertown, Massachusetts, develops long-lasting, high-dose local chemotherapy products on its Sagittari platform, designed to deliver drug continuously at the tumour site. Its lead, PTM-101, is described in the registry as an absorbable drug product containing paclitaxel, tested as an adjunct to neoadjuvant therapy in treatment-naive borderline resectable and locally advanced pancreatic ductal adenocarcinoma in a phase 1b study (NCT06673017) with US and Australian sites; the company reported completing its first cohort in September 2025 and dose escalation in May 2026. The company lists a USD 1.8 million supplemental award from the Cancer Prevention and Research Institute of Texas in May 2026. Its first registered cancer trial, NCT06673017, was posted on ClinicalTrials.gov in November 2024.

## Fields

- Kind: Company
- Last checked: 2026-10-29
- HQ: Austin, TX
- Type: biotech
- Website: https://panthertx.com/

## Notes

- Founding year and venture financing not stated on the company website.
- The USD 1.8 million CPRIT figure is from the company's news list; the CPRIT page returned HTTP 403 and the Business Wire releases returned 403 on 29 October 2026, so no funding row is recorded.
- The website lists Austin and Watertown without naming a headquarters; Austin is used.

## Sources

- Official website: https://panthertx.com/
- Company news: https://panthertx.com/news
- ClinicalTrials.gov: phase 1b trial of PTM-101 (NCT06673017): https://clinicaltrials.gov/study/NCT06673017

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- fronts: [Chemotherapy](https://onco.cc/fronts/chemotherapy/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)

---
JSON: https://onco.cc/api/v1/entities/panther-therapeutics.json